Karthikeya Logo
KARTHIKEYA Speciality Clinics
Book Consultation Call: +91 79957 56828
General Surgery & Surgical Oncology

Gynecological Cancers & Benign Surgeries

Comprehensive surgical staging and treatment for Uterine/Endometrial cancer, Ovarian tumors, Cervical cancer, and complex benign fibroids/ovarian cysts.

Clinical Focus: Gynecological oncology encompasses the diagnosis, surgical staging, and cytoreductive management of malignancies affecting the female reproductive tract. Dr. Malyadri Paladugu provides specialized surgical care for uterine, ovarian, cervical, and vulvar cancers, offering both advanced laparoscopic/robotic hysterectomies and radical open cytoreductive procedures.

Conditions Evaluated & Surgically Managed

  • Endometrial / Uterine Cancer: Post-menopausal bleeding evaluation, Laparoscopic/Robotic Radical Hysterectomy, Bilateral Salpingo-Oophorectomy, and Pelvic/Para-Aortic Lymph Node Staging.
  • Ovarian Cancer (Epithelial & Germ Cell): Complete surgical staging, primary and interval Cytoreductive Surgery (CRS), and complex pelvic peritonectomy.
  • Cervical Cancer: Radical Hysterectomy (Wertheim’s Operation) with bilateral pelvic lymphadenectomy for early-stage disease; surgical staging for locally advanced tumors.
  • Vulvar & Vaginal Malignancies: Radical Vulvectomy with inguinofemoral lymph node dissection.
  • Complex Benign Gynecological Conditions: Large uterine fibroids, severe endometriosis, ovarian dermoid cysts, and total laparoscopic hysterectomy (TLH).

Comprehensive Pre-Operative Diagnostic Protocol

Endometrial Biopsy / Pipelle

Office pipelle sampling or hysteroscopic D&C for histopathological and molecular subtype confirmation.

Tumor Marker Panel

Serum CA-125, HE4, CEA, CA 19-9, Beta-hCG, and AFP with ROMA score calculation for pelvic masses.

Pelvic MRI & PET-CT Staging

High-resolution dedicated Pelvic MRI with contrast to evaluate myometrial invasion depth and cervical stromal involvement.

Operative Precision & Survivorship Care

  1. Optimal Cytoreduction: Striving for complete gross resection (R0 resection) in ovarian malignancies, the single most critical prognostic factor for survival.
  2. Nerve-Sparing Radical Dissections: Preserving bladder and bowel autonomic nerves to prevent post-operative urinary retention and dysfunction.
  3. Fertility-Sparing Oncology: In carefully selected young patients with early-stage disease, exploring fertility-preserving surgical alternatives.
  4. Post-Surgical Tumor Board Review: Coordinating adjuvant chemotherapy or brachytherapy/radiation protocols based on final histopathology.

Why Choose Karthikeya Speciality Clinics

  • Surgical Oncology Specialization: Sub-speciality expertise in retroperitoneal dissection and radical pelvic cancer surgery.
  • Minimally Invasive Hysterectomy: Robotic and laparoscopic capabilities ensuring small incisions, low blood loss, and rapid healing.
  • Comprehensive Cancer Center Infrastructure: Backed by tertiary level critical care, blood bank, and medical oncology facilities at Yashoda Hospital.
  • Dedicated Patient Support: Continuous postoperative follow-ups, hormone replacement advice where safe, and survivorship monitoring.

Frequently Asked Questions

Any post-menopausal vaginal bleeding, even slight spotting or brownish discharge, is an abnormal warning sign that must be investigated promptly with an ultrasound and endometrial biopsy. Early detection offers cure rates exceeding 90%.
Cytoreductive surgery (debulking) involves surgically removing all visible tumor deposits from the ovaries, uterus, fallopian tubes, omentum, peritoneum, and adjacent pelvic organs to leave no macroscopic residual disease.
Yes. Laparoscopic and robotic radical hysterectomy with lymph node dissection is currently the gold-standard preferred approach for early endometrial cancer, resulting in quick recovery and minimal hospital stay.